EP3241843
Leysnibestun ónæmisbindiefnis
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.6.2009EP published:
28.7.2021EP application number:
17161990.1
EP translation filed:
24.8.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
24.6.2029Expiry date:
24.6.2026Next due date:
30.6.2026
Title:
SOLUBILITY OPTIMIZATION OF IMMUNOBINDERS
Timeline
Today
25.6.2009EP application
28.7.2021EP Publication
24.8.2021Translation submitted
15.9.2021Registration published
24.6.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
BORRAS, LeonardoAddress:
4056 Basel, CH
Name:
URECH, DavidAddress:
4056 Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
75692 PDate:
25.6.2008Country:
US
Classification
Categories:
C07K 16/22, C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 24.5.2022
Expires: 24.6.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 24.5.2023
Expires: 24.6.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 23.5.2024
Expires: 24.6.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 12.6.2025
Expires: 24.6.2026
Payer: Árnason Faktor ehf.